BASFs, Evonik

BASF's Evonik Charm Offensive Runs Into a Blanks Problem

Published on 11/18/2026 at 06:10 | Editorial boerse-global.de
BASF is seeking backing from NRW politicians and the RAG-Stiftung for a fresh Evonik approach, but draft pledges may lack new money.
BASFs, Evonik, Charm, Offensive, Runs, Into, Blanks, Problem, BASF, NRW Illustration mit AI erstellt.

BASF is leaning on politicians and the RAG-Stiftung to unlock a fresh attempt at Evonik, but the draft concessions now circulating in Düsseldorf and Essen may not carry enough new money to move the needle. Reuters and Bloomberg reported that the chemicals group is sounding out state officials in North Rhine-Westphalia and Evonik's largest shareholder over extra job and site commitments, with a sweetened offer potentially landing within days at a price that remains undisclosed.

The gap between what BASF is offering and what sceptics want comes down to additionality. According to Reuters, BASF sketched out possible pledges on sites, jobs and apprenticeships in a letter to the state government and the RAG-Stiftung — but the document still carries placeholders where timeframes and investment sums should sit. Bloomberg's account goes further, suggesting BASF could rule out compulsory redundancies for a period still to be negotiated, keep every German production site, and add spending on research and development plus the low-carbon conversion of its plants.

A template already on the table

Much of that ground has been covered before. The Handelsblatt, citing a draft dated 11 November, reported plans to roll over existing employee commitments and keep the Marl and Wesseling chemical parks running, with Essen retained as a group location hosting a board division responsible for more than EUR 10 billion in revenue. Back in late October, BASF had already promised to take on Evonik's employment guarantees through 2032 and to keep Marl and Wesseling operating with roughly 3,500 jobs.

That history is precisely the problem. Insiders quoted by the Handelsblatt see little material substance beyond what has already been pledged, and Evonik works council representative Hussin El Moussaoui made the same point — restating the status quo creates no added value. Repeating known guarantees, in other words, looks unlikely to dislodge the reservations on the labour side.

Should investors sell immediately? Or is it worth buying BASF?

The price of protection

For BASF, the trade-off is becoming explicit. Deeper commitments may smooth the path to approval, yet employment and site guarantees can blunt the savings that job cuts or consolidation would otherwise deliver — and that in turn caps the takeover price the company can economically justify. Investors weighing the next move will need more than a headline offer figure; the duration of any guarantees and the size of binding investment pledges matter just as much. Until those blanks are filled, the financial weight of the package cannot be properly assessed. Neither company would comment to Dow Jones.

Evonik has already turned down an improved bid worth more than EUR 11 billion, or EUR 24 per share, so any new approach would not be the first attempt to win over the target. Support from the RAG-Stiftung, as Evonik's biggest shareholder, would carry particular weight, and BASF is simultaneously courting lawmakers for backing.

Portfolio surgery on two fronts

The charm offensive sits alongside a broader reshaping of the portfolio. Last week BASF agreed to sell its mining solutions business to SNF — a deal in which it plays the seller, in contrast to its buyer's role in the Evonik pursuit. On 11 November the group started up its new MDI plant at the Geismar integrated site in Louisiana, an investment of around USD 1 billion that lifts annual capacity there to roughly 600,000 tonnes. A day earlier, BASF said the power supply for its European polyisobutene production would be switched over, with eligible output for external customers set to run entirely on renewable electricity from January 2027.

BASF at a turning point? This analysis reveals what investors need to know now.

Market backdrop

The stock closed at EUR 52.12 on the day it fell 2.9%, caught in a broad sell-off of European equities. Reuters attributed the risk-off tone to caution ahead of Nvidia's results, losses in AI-related shares and further US restrictions on AI chip exports to China. Shares also slipped after the report that BASF was weighing further concessions to win approval for the Evonik deal.

Ad

BASF Stock: New Analysis - 18 November

Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BASF analysis...

Disclaimer...
en | DE000BASF111 | BASFS | boerse | 70529524 |